PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment
Alessandro Orsini(University of Pisa), Alice Bonuccelli(University of Pisa), Ilaria Trivelli(Azienda Ospedaliera Universitaria Pisana), Gabriella Casazza(Azienda Ospedaliera Universitaria Pisana), Thomas Foiadelli(Policlinico San Matteo Fondazione), Niccolò Carli(University of Pisa), Sayla Bernasconi(Azienda Ospedaliera Universitaria Pisana), Diego Peroni, Pasquale Striano(Great Ormond Street Hospital), Andrea Santangelo(University of Pisa), Margherita Nardi(Azienda Ospedaliera Universitaria Pisana), Maria Cristina Bianchi(Azienda Ospedaliera Universitaria Pisana), Maria Esposito(University of Campania "Luigi Vanvitelli"), Mariacristina Menconi(Azienda Ospedaliera Universitaria Pisana)
CINECA IRIS Institutial research information system (University of Pisa)
January 1, 2021
Cited by 3
Related Papers
Mapping the human genetic architecture of COVID-19
|Nature|2021|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|252